Contempo: Preliminary Results in First-Line Treatment of Follicular Lymphoma with the Oral Dual PI3K-δ,γ Inhibitor, Duvelisib, in Combination with Rituximab or Obinutuzumab
暂无分享,去创建一个
R. Advani | S. Mercadal | J. Sancho | M. Merli | J. Pearlberg | A. Goy | E. Gyan | C. Casulo | K. Bouabdallah | S. Vos | H. Holmes | J. Lemmens | K. Eygen | L. Steelman | R. Johnson | Kamal Bouabdallah